65 /100
HIGH RISK
Score updated May 30, 2026

RGBP — Regen BioPharma, Inc. Dilution Risk Tracker

Track RGBP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RGBP — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
95
📊 Float Risk
17
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
33%
🔁 Convertible Conversion 60%
• Major convertible overhang: 2701% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration 10%
• Score in HIGH risk zone (65/100)
🔔 Track RGBP — Get forecast alerts →

💹 Market Data

Market Cap$153.6K
Shares Outstanding511.96M
Float461.18M
Cash$271
Debt$959.1K
Short InterestN/A

🏛 Institutional Holdings

Institutional data not yet available.

📉 Short Interest

Short Interest353.3K
Days to Cover1.0
% of Float0.1%
FINRA data as of Mar 31, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Sep 30, 2024
xbrl XBRL CONVERTIBLE Jun 30, 2020
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track RGBP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RGBP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: BATL BRN CDIO CDT CNTMD
🔬 More Research for RGBP
📊 RGBP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 RGBP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.